News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

PharmTech Europe March 2026

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Pharma's Digital, Scientific, and Manufacturing Evolution

ByMike Hennessy Jr.

March 30th 2026

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

The Impact of New Pharmaceutical and HTA Legislation in Europe

ByCheryl Barton

March 26th 2026

New legislation will improve patient access to innovative medicines in Europe and the United Kingdom.

Proteasomes are molecular machines for breaking down proteins called proteolysis, only target proteins that have been marked for destruction called ubiquitin to the target protein, 3d rendering | Image Credit: ©Love Employee -stock.adobe.com

Proteasomes: A Novel Approach to Target the Immune System

ByCheryl Barton

Published: January 20th 2026 | Updated: February 13th 2026

Proteasome-targeting therapies may eliminate disease-causing proteins in a broad range of diseases.

Trending on Pharmaceutical Technology

FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps

Germany Pharma Tariff Threat: What Manufacturers Need to Know

PharmTech Weekly Roundup—June 19, 2026

Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next

Why the First Generic Single-Dose Flu Antiviral Approval Matters